Imaging biomarkers correlate with efficacy of bevacizumab combined with conventional therapy in newly diagnosed glioblastoma: an open-label, single arm trial

Conclusions: 18F-RGD PET/CT may be valuable in assessing the response of glioblastoma to treatment with the combination of Avastin and CCRT, with a greater decrease in SUVmean predicting better PFS.

Source: Journal of Nuclear Medicine - May 20, 2019 Category: Nuclear Medicine Authors: Li, L., Yuan, S., Yu, J., Liu, N., Hui, Z., Tao, R., Zhao, S., Xu, L., Liu, Y., Gao, Y. Tags: Brain Imaging Reloaded II Source Type: research